The global glioblastoma multiforme treatment market size was valued at USD 2.78 billion in 2024 and is expected to reach around USD 5.68 billion by 2033, registering a CAGR of 8.23% from 2024 to 2033.
It’s a key component of treatment for patients with metastatic NSCLC. After radiation, surgery, or systemic treatment for brain metastases, your doctor will most likely order an MRI to determine ...